UCB · 3 months ago
Clinical Development Lead - Raleigh
UCB is a global biopharmaceutical company focusing on neurology and immunology. They are seeking a Clinical Development Lead to drive innovative clinical strategies and oversee global development programs, ensuring alignment with regulatory requirements and commercial goals.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Set the global clinical development strategy for assigned asset(s), ensuring alignment with TPVP, regulatory requirements, and commercial goals
Lead external engagement with global thought leaders, investigators, and stakeholders to continuously refine strategy based on emerging insights and unmet needs
Design and adapt robust clinical development plans that integrate the latest scientific, regulatory, operational, and payer perspectives—balancing innovation with executional feasibility
Oversee the execution of pivotal studies and regulatory submissions across all relevant markets, ensuring clinical excellence, data integrity, and timely delivery
Shape clinical narratives and regulatory strategy, acting as a key representative in interactions with global health authorities and strategic partners
Contribute to corporate strategy, supporting business development initiatives and representing the clinical perspective in asset evaluations
Qualification
Required
Advanced degree (MD, PhD, PharmD, or equivalent)
Preferred
Track record of leading complex global programs across multiple indications
Familiarity with digital health technologies, real-world data, and AI-enabled trial innovation
Ability to lead through ambiguity, make informed decisions in uncertainty, and drive results across organizational boundaries
Strategic mindset with a bias for innovation, speed, and operational excellence
Exceptional communication and stakeholder management skills, including C-suite level
Global experience and cultural fluency; willingness to travel internationally as needed
Company
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
Funding
Current Stage
Public CompanyTotal Funding
$201.75MKey Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M
Leadership Team
Recent News
Company data provided by crunchbase